ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 108 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $233,000 | -65.0% | 33,986 | -78.7% | 0.00% | -66.7% |
Q2 2020 | $665,000 | +711.0% | 159,445 | +381.7% | 0.00% | – |
Q1 2020 | $82,000 | +182.8% | 33,098 | +559.5% | 0.00% | – |
Q4 2019 | $29,000 | -80.0% | 5,019 | -68.7% | 0.00% | -100.0% |
Q1 2019 | $145,000 | +31.8% | 16,044 | +16.0% | 0.00% | – |
Q2 2018 | $110,000 | +86.4% | 13,833 | +74.7% | 0.00% | – |
Q1 2018 | $59,000 | +55.3% | 7,918 | +43.1% | 0.00% | – |
Q4 2017 | $38,000 | – | 5,534 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |